glucose, (beta-d)-isomer has been researched along with Polyuria in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Tsao, G; Saffo, S; Taddei, T | 1 |
| Johnsson, E; Johnsson, K; Mansfield, TA; Parikh, SJ; Ptaszynska, A; Yavin, Y | 1 |
| Hantel, S; Heise, T; Macha, S; Pinnetti, S; Seewaldt-Becker, E; Seman, L; Woerle, HJ | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Polyuria
| Article | Year |
|---|---|
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes.
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Germany; Glucosides; Glycosuria; Humans; Hyperglycemia; Hypoglycemic Agents; Incidence; Male; Membrane Transport Modulators; Middle Aged; Polyuria; Sodium-Glucose Transporter 2 Inhibitors | 2013 |
2 other study(ies) available for glucose, (beta-d)-isomer and Polyuria
| Article | Year |
|---|---|
SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Outcome Assessment, Health Care; Polyuria; Sodium-Glucose Transporter 2 Inhibitors; Tertiary Care Centers; Urinary Tract Infections; Young Adult | 2021 |
Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials.
Topics: Age Factors; Aged; Benzhydryl Compounds; Blood Pressure; Blood Urea Nitrogen; Diuresis; Female; Fractures, Bone; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Hypotension, Orthostatic; Hypovolemia; Incidence; Male; Middle Aged; Osmosis; Placebos; Polyuria; Randomized Controlled Trials as Topic; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |